Related Experiment Video
Updated: Aug 15, 2026
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Intravesical gemcitabine for superficial bladder cancer: rationale for a new treatment option
Paolo Gontero1, Luca Marini, Bruno Frea
1Clinica Urologica, University of Piemonte Orientale, Novara, Italy. gontero@med.unipmn.it
BJU International
|October 18, 2005
Abstract
No abstract available in PubMed .